Vivos Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Vivos Therapeutics, Inc.

Welcome to our dedicated page for Vivos Therapeutics, Inc. (Nasdaq: VVOS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Vivos Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Vivos Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for VVOS
TickerTime & DateFilingLink
VVOS01:58:39 AM, 06/21/2023
Huntsman Ronald Kirk(Chief Executive Officer) purchased 14000 shares of Vivos Therapeutics, Inc. (VVOS) for ~$7420
Filing
VVOS10:10:09 AM, 06/20/2023
Huntsman Ronald Kirk(Chief Executive Officer) purchased 15021 shares of Vivos Therapeutics, Inc. (VVOS) for ~$8060
Filing
VVOS11:15:31 PM, 06/15/2023
Huntsman Ronald Kirk(Chief Executive Officer) purchased 10000 shares of Vivos Therapeutics, Inc. (VVOS) for ~$4900
Filing
VVOS02:45:36 AM, 12/29/2022
Huntsman Ronald Kirk(Chief Executive Officer) purchased 20000 shares of Vivos Therapeutics, Inc. (VVOS) for ~$10000
Filing